Ruxolitinib for essential thrombocythemia refractory to or intolerant of hydroxyurea: long-term phase 2 study results
Verstovsek, Srdan, Passamonti, Francesco, Rambaldi, Alessandro, Barosi, Giovanni, Rumi, Elisa, Gattoni, Elisabetta, Pieri, Lisa, Zhen, Huiling, Granier, Muriel, Assad, Albert, Cazzola, Mario, Kantarjian, Hagop M., Barbui, Tiziano, Vannucchi, Alessandro M.
Published in Blood (12.10.2017)
Published in Blood (12.10.2017)
Get full text
Journal Article
A Phase 1/2 Study to Evaluate the Safety and Efficacy of Ponatinib with Chemotherapy in Pediatric Patients with Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)
Matloub, Yousif, Gore, Lia, Loh, Mignon L., Pui, Chin-Hon, Hanley, Michael J., Lu, Vickie, Leonard, E. Jane, Granier, Muriel, Biondi, Andrea, Silverman, Lewis B.
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
ALL-049 A Phase 1/2 Study to Evaluate Ponatinib With Chemotherapy in Pediatric Patients With Relapsed/Resistant/Intolerant Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia or With T315I Mutation
Gore, Lia, Loh, Mignon, Pui, Ching-Hon, Matloub, Yousif, Hanley, Michael J., Du, Jichang, Hennessy, Meliessa, Granier, Muriel, Biondi, Andrea, Silverman, Lewis
Published in Clinical lymphoma, myeloma and leukemia (01.10.2022)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2022)
Get full text
Journal Article
Poster: ALL-049 A Phase 1/2 Study to Evaluate Ponatinib With Chemotherapy in Pediatric Patients With Relapsed/Resistant/Intolerant Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia or With T315I Mutation
Gore, Lia, Loh, Mignon, Pui, Ching-Hon, Matloub, Yousif, Hanley, Michael J., Du, Jichang, Hennessy, Meliessa, Granier, Muriel, Biondi, Andrea, Silverman, Lewis
Published in Clinical lymphoma, myeloma and leukemia (01.10.2022)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2022)
Get full text
Journal Article
INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph+ acute lymphoblastic leukemia
Martinelli, Giovanni, Papayannidis, Cristina, Piciocchi, Alfonso, Robustelli, Valentina, Soverini, Simona, Terragna, Carolina, Marconi, Giovanni, Lemoli, Roberto M., Guolo, Fabio, Fornaro, Antonella, Lunghi, Monia, de Fabritiis, Paolo, Candoni, Anna, Selleri, Carmine, Simonetti, Federico, Bocchia, Monica, Vitale, Antonella, Frison, Luca, Tedeschi, Alessandra, Cuneo, Antonio, Bonifacio, Massimiliano, Martelli, Maria Paola, D'Ardia, Stefano, Trappolini, Silvia, Tosi, Patrizia, Galieni, Piero, Fabbiano, Francesco, Abbenante, Maria Chiara, Granier, Muriel, Zhu, Zhaoyin, Wang, Mingyue, Sartor, Chiara, Paolini, Stefania, Cavo, Michele, Foà, Robin, Fazi, Paola, Vignetti, Marco, Baccarani, Michele
Published in Blood advances (22.03.2022)
Published in Blood advances (22.03.2022)
Get full text
Journal Article
Poster: ALL-167: A Phase 1/2 Study to Evaluate the Safety and Efficacy of Ponatinib with Chemotherapy in Pediatric Patients with Relapsed, Resistant, or Intolerant Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) or Have the T315I Mutation
Gore, Lia, Loh, Mignon, Pui, Ching-Hon, Hanley, Michael J., Du, Jichang, Matloub, Yousif, Hennessy, Meliessa, Granier, Muriel, Biondi, Andrea, Silverman, Lewis
Published in Clinical lymphoma, myeloma and leukemia (01.09.2021)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2021)
Get full text
Journal Article
ALL-167: A Phase 1/2 Study to Evaluate the Safety and Efficacy of Ponatinib with Chemotherapy in Pediatric Patients with Relapsed, Resistant, or Intolerant Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) or Have the T315I Mutation
Gore, Lia, Loh, Mignon, Pui, Ching-Hon, Hanley, Michael J., Du, Jichang, Matloub, Yousif, Hennessy, Meliessa, Granier, Muriel, Biondi, Andrea, Silverman, Lewis
Published in Clinical lymphoma, myeloma and leukemia (01.09.2021)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2021)
Get full text
Journal Article
Targeting the Tumor Microenvironment through mTOR Inhibition and Chemotherapy as Induction Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma: The CAPRA Study
Evrard, Diane, Dumont, Clément, Gatineau, Michel, Delord, Jean-Pierre, Fayette, Jérôme, Dreyer, Chantal, Tijeras-Raballand, Annemilaï, de Gramont, Armand, Delattre, Jean-François, Granier, Muriel, Aissat, Nasredine, Garcia-Larnicol, Marie-Line, Slimane, Khemaies, Chibaudel, Benoist, Raymond, Eric, Le Tourneau, Christophe, Faivre, Sandrine
Published in Cancers (01.09.2022)
Published in Cancers (01.09.2022)
Get full text
Journal Article
BIOSHARE multicenter neoadjuvant phase 2 study: Results of pre-operative sorafenib in patients with resectable hepatocellular carcinoma (HCC)—From GERCOR IRC
Bouattour, Mohamed, Fartoux, Laetitia, Rosmorduc, Olivier, Scatton, Olivier, Vibert, Eric, Costentin, Charlotte, Soubrane, Olivier, Ronot, Maxime, Granier, Muriel Magali, De Gramont, Armand, Belghiti, Jacques, Paradis, Valerie, Wendum, Dominique, Tijeras-Raballand, Annemilai, Hadengue, Alexandra, Brusquant, David, Chibaudel, Benoist, Raymond, Eric, Faivre, Sandrine J.
Published in Journal of clinical oncology (01.02.2016)
Published in Journal of clinical oncology (01.02.2016)
Get full text
Journal Article
CAPRA: Safety, efficacy, and translational biomarkers of weekly everolimus, carboplatin, and paclitaxel as induction therapy for locally advanced head and neck squamous cell carcinoma (HNSCC)
Raymond, Eric, Le Tourneau, Christophe, Gatineau, Michel, Delord, Jean-Pierre, Fayette, Jérôme, Dreyer, Chantal, Tijeras-Raballand, Annemilai, Albert, Sebastien, Granier, Muriel, Chibaudel, Benoist, Hadengue, Alexandra, Aissat, Nasredine, Slimane, Khemaies, Faivre, Sandrine J.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article